The Venture Codex Logo

The Venture Codex

Impact Ventures UK

71-75 Shelton St, London, WC2H 9JQ, United Kingdom

Overview

Impact Ventures UK (IVUK) is a growth capital impact fund managed by LGT Venture Philanthropy (LGT VP) and launched in partnership with Berenberg. They have seen the emergence of innovative and competitive business models being developed to improve the quality of life of disadvantaged individuals in the UK. IVUK was founded to invest in and support these enterprises. They are focused on delivering and measuring social impact through a professionalised framework established over the last seven years by LGT VP across the globe.

Total investments
2
Lead investments
0
Investments · 12mo
0
Active investors
7

Sector focus

  • Finance
  • Financial Services
  • Venture Capital
Visit website

Investment portfolio

  • Togetherall

    Participated · Equity · Nov 2020

    Togetherall operates a population-based, clinically managed online community that offers 24/7 anonymous peer-to-peer support moderated by trained practitioners and a library of self-help courses and resources. The platform is available in the UK, New Zealand, Canada and the US and is positioned as a SaaS business serving higher education, corporate and health sectors. Founded in 2007, Togetherall says it has helped over a quarter of a million members to date and supported nearly 90,000 individuals in the last 12 months. The service is moderated around the clock to ensure a safe environment and aims to reduce barriers and stigma to accessing mental-health support. The company is accelerating product development and expanding resources to meet growing demand and to support further North American growth, especially in the US.

  • Elvie

    Participated · Series B · Apr 2019

    Elvie develops consumer-focused women’s health products designed to replace outdated medical devices with sleek, home-friendly alternatives. Its product lineup includes the Elvie Trainer app-connected Kegel trainer, the Elvie Pump silent wearable breast pump, and breastfeeding accessories Elvie Catch and Elvie Curve. The company was founded in 2013 by Tania Boler and is headquartered in London. Elvie aims to revolutionise categories such as breast pumps and pelvic-floor health by combining engineering, design, and consumer UX. Financially, Elvie has completed multiple fundraises, bringing total funding to $136 million to date from backers that include BlackRock, Octopus Ventures, and the Business Growth Fund. The most recent capital is intended to enhance women’s well-being and support the company’s product and category expansion. Elvie is a British femtech company that designs consumer health products for women, including the Elvie Pump and app-connected Elvie Trainer. The company has four products on market—Elvie Trainer, Elvie Pump, Elvie Catch and Elvie Curve—and has commercialized two breakthrough, patented and FDA-approved devices. Since launching Elvie Pump in 2018 the business experienced rapid growth, growing 6x in 2019, almost doubling in 2020 and on track to double again in 2021, while launching 10 new markets across Europe and Asia and gaining the No.1 position for Elvie Pump in the US and UK. Elvie plans to expand its product portfolio into other key life stages to become a global platform for women’s health. The Series C proceeds will be used to fund product innovation, geographic expansion and to strengthen operations and infrastructure for the next phase of growth. Elvie is a six-year-old, London-based femtech hardware company known for an app-connected Kegel trainer and a silent wearable breast pump. Its Kegel trainer provides five-minute workouts with real-time biofeedback, while the pump monitors milk volume in real time, tracks pumping history per breast and can be operated remotely. The pump launched in September and had a waitlist of thousands of women. Elvie's long-term plan is to develop products supporting women at every stage of life — prenatal, menopausal and otherwise — and to become a one-stop shop for women's health. Financially, the company has raised nearly $50 million to date and announced a $42 million Series B as its third private financing. The new capital will be used for R&D on upcoming products and to build brand awareness and distribution across the U.S., Canada, Europe and Asia. Launched in 2013, Elvie develops consumer technology focused on women’s health, notably a pelvic floor exercise tracker paired with a mobile app. Its tracker is distributed through major retailers and e-tailers including Amazon, John Lewis, Goop and Violet Grey. The company already operates in 59 countries and generated $1 million in direct sales revenue in 2016. Elvie plans to use new funding to expand into 25 additional countries across the Americas, Europe and Asia-Pacific. It also intends to launch a second device aimed specifically at new mothers before the end of 2017. The business has previously raised seed funding and received government grants to support development and growth.

Team